What’s worth some 1,204.8 billion USD? Well, it’s the worldwide pharmaceutical market, of course! With such a capital at stake and with the pace of technological disruption, the pharma industry is quick to adapt to the changing times. In fact, leading drug companies are re-investing as much as 20.8% of drug sales into new drug development. We’ve analyzed the trends shaping the future of pharma before, but how can we expect to see the landscape evolve in this new decade? With leaps in A.I., patient empowerment and 3D printed drugs, here are the 5 pharma trends that will be the focus of pharmaceutical companies in the coming years.
Pharma Trend #1 – Faster and cheaper: A.I. for drug R&D
A recent report forecasts the global artificial intelligence in healthcare market size to reach the USD 31.3 billion bar by 2025, growing at a compound annual growth rate (CAGR) of 41.5% over a forecast period. Pharma companies’ contribution to this growth isn’t negligible, as the sheer amount of A.I. companies in drug development reflects. It’s all about the speed and savings that A.I. ‘s myriad of applications can bring in this sector.
Read the full article in The Medical Futurist website